Current Practices and Considerations for a Stability-Indicating Method in Pharmaceutical Analysis
What are the characteristics and relevant considerations for the development and validation of a stability-indicating method?
In the pharmaceutical industry, the demonstration of drug substance (DS) or drug product (DP) stability over the shelf life is an important aspect of the regulatory requirements.